Drug
Trosunilimab clinical trials
Also written ABBV-382.
Keep track of what changes. Save the trosunilimab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
5 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Often tested with
Tested in the same studies.
Risankizumab (2) · ABBV-701 (1) · Lutikizumab (1) · ABBV-8736 (1) · Budigalimab (1)
Studies
Open first, then newest update. How each study uses trosunilimab is read from its arms, and is right about nine times in ten.
Testing it · 5
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisRecruitingPhase 2AbbVieNCT07697456Written as Trosunilimab
- Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseRecruitingPhase 2AbbVieNCT06548542Written as Trosunilimab
- A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382TerminatedPhase 2AbbVieNCT06032546Written as ABBV-382
- A Study to Evaluate Adverse Events and How the Drug Moves Through the Body From Subcutaneous (SC) and Intravenous (IV) Doses of ABBV-382 in Healthy Adult Chinese VolunteersCompletedPhase 1AbbVieNCT06632938Written as ABBV-382
- Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)CompletedPhase 1AbbVieNCT04554966Written as ABBV-382
Codes
What other systems call trosunilimab · ClinicalTrials.gg INT017200
- UNII (FDA) LNN5K7KB5RTROSUNILIMABOne source FDA
- NCI Thesaurus C207007TrosunilimabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | LNN5K7KB5R | TROSUNILIMAB | One source FDA |
| NCI Thesaurus | C207007 | Trosunilimab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.